About heather

This author has not yet filled in any details.
So far heather has created 733 blog entries.

APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development

STONY BROOK, N.Y. – April 1, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that Clay Shorrock, J.D., has rejoined the Company effective immediately to serve on the executive leadership team as Chief Legal Officer and Executive Director, [...]

An interview with Dr. James Hayward, Chairman, President & CEO

As COVID-19 circumnavigated the globe, scientists representing many disciplines rose to meet it. Among them: James Hayward and the incredible minds at Stony Brook-based Applied DNA Sciences, where long experience and a unique technology set the pace. A molecular biologist by trade, Hayward brings decades of biotech and consumer-product experience to his [...]

2022-11-03T14:56:01-04:00Categories: APDN in the News|Tags: , , , |

APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits

STONY BROOK, N.Y. March 11, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the receipt of a purchase order for its Linea™ COVID-19 Assay Kit (the “Assay Kit”) and consumables to conduct 10,000 tests under a Master Services Agreement with [...]

Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel

STONY BROOK, N.Y. March 10, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the launch of its Linea™ COVID-19 Selective Genomic Surveillance™ (SGS) Mutation Panel (the “SGS Panel”) to enhance the utility of limited Next Generation Sequencing [...]

Applied DNA to Participate in Upcoming Conferences

STONY BROOK, N.Y. March 8, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor conferences. March 9 – 10, 2021 – Dr. James A. Hayward, president and CEO, will present a company [...]

Cannabis Partnerships | The Importance of Building a Successful Business

By John Shearman, VP of Marketing, Cannabis, Applied DNA Sciences The grass roots of the cannabis industry fostered, often through necessity, a strong sense of community and encouraged innovation and sharing of techniques and methods to cultivate the various strains of cannabis. Learning from what has come before and working together in [...]

2022-11-03T15:02:52-04:00Categories: APDN in the News|Tags: , , |

Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines

- COVID Feline Vaccine Candidate Previously Demonstrated Antibodies and T-cell Response in Mouse Models - - Clinical Trial to Serve as Initial Validation of LinearDNA Platform in Large Mammals with Potential Advantages in Manufacturing, Storage, and Distribution over Other Vaccines - STONY BROOK, N.Y. & ROME. March 2, 2021. Applied [...]

APDN Granted US Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication

STONY BROOK, N.Y. February 25, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has received United States Patent No. 10,920,274 entitled “Nucleic Acid Coated Submicron Particles for Authentication” from the United States Patent and [...]

Go to Top